Acute Undifferentiated Fever in Ethiopia
Causes of Acute Undifferentiated Fever and the Utility of Biomarkers in Differentiating Bacterial From Viral Infection Among Acute Febrile Patients in Northwest Ethiopia
1 other identifier
observational
200
2 countries
2
Brief Summary
A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in differentiating bacterial from viral infection among acute febrile patients in Gondar, northwest Ethiopia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2019
CompletedFirst Submitted
Initial submission to the registry
February 11, 2020
CompletedFirst Posted
Study publicly available on registry
February 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedMay 11, 2021
May 1, 2021
3 months
February 11, 2020
May 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The differentiation of bacterial infections and viral infections among acute febrile patients with biomarkers
CRP (bacterial biomarker) and MxA (viral biomarker) will be evaluated for differentiating confirmed bacterial and viral infections.
within 7 days after onset of fever
Secondary Outcomes (3)
The number of malaria cases, bacterial infections, viral infections and unknown etiologies among acute febrile patients in Gondar
within 7 days after onset of fever
The comparison of different assays for diagnosis of DENV
within 7 days after onset of fever
The comparison of the qualitative and qualitative detection of CRP for differentiating bacterial and viral infections
within 7 days after onset of fever
Eligibility Criteria
All patients ≥ 15 years old with acute undifferentiated fever and seeking health services within 7 days after fever onset at the emergency ward of the university of Gondar hospital (Ethiopia) during the study period.
You may qualify if:
- Patients presenting with acute fever (an axillary temperature of ≥37.5°C; symptom duration ≤7 days)
- ≥ 15 years old
- signed informed consent
You may not qualify if:
- pregnant woman \& children (\<15 y)
- febrile patient suspected of urinary tract infection or acute respiratory tract infection
- Individuals who had taken antimicrobial and antimalarial drug in the last 2 weeks
- Patients with acute injury or trauma or for which participation in the study implies an unacceptable health risk as determined by the physicians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Tropical Medicine, Belgiumlead
- University of Gondarcollaborator
Study Sites (2)
Institute of Tropical Medicine
Antwerp, 2000, Belgium
University of Gondar
Gonder, Ethiopia
Related Publications (7)
Bhargava A, Ralph R, Chatterjee B, Bottieau E. Assessment and initial management of acute undifferentiated fever in tropical and subtropical regions. BMJ. 2018 Nov 29;363:k4766. doi: 10.1136/bmj.k4766. No abstract available.
PMID: 30498133BACKGROUNDMohammed Yusuf A, Abdurashid Ibrahim N. Knowledge, attitude and practice towards dengue fever prevention and associated factors among public health sector health-care professionals: in Dire Dawa, eastern Ethiopia. Risk Manag Healthc Policy. 2019 Jun 7;12:91-104. doi: 10.2147/RMHP.S195214. eCollection 2019.
PMID: 31239796BACKGROUNDFerede G, Tiruneh M, Abate E, Wondimeneh Y, Damtie D, Gadisa E, Howe R, Aseffa A, Tessema B. A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures. PLoS Negl Trop Dis. 2018 May 31;12(5):e0006430. doi: 10.1371/journal.pntd.0006430. eCollection 2018 May.
PMID: 29852020BACKGROUNDLilay A, Asamene N, Bekele A, Mengesha M, Wendabeku M, Tareke I, Girmay A, Wuletaw Y, Adossa A, Ba Y, Sall A, Jima D, Mengesha D. Reemergence of yellow fever in Ethiopia after 50 years, 2013: epidemiological and entomological investigations. BMC Infect Dis. 2017 May 15;17(1):343. doi: 10.1186/s12879-017-2435-4.
PMID: 28506254BACKGROUNDAnimut A, Mekonnen Y, Shimelis D, Ephraim E. Febrile illnesses of different etiology among outpatients in four health centers in Northwestern Ethiopia. Jpn J Infect Dis. 2009 Mar;62(2):107-10.
PMID: 19305049BACKGROUNDKapasi AJ, Dittrich S, Gonzalez IJ, Rodwell TC. Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review. PLoS One. 2016 Aug 3;11(8):e0160278. doi: 10.1371/journal.pone.0160278. eCollection 2016.
PMID: 27486746BACKGROUNDSelf WH, Rosen J, Sharp SC, Filbin MR, Hou PC, Parekh AD, Kurz MC, Shapiro NI. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections. J Clin Med. 2017 Oct 7;6(10):94. doi: 10.3390/jcm6100094.
PMID: 28991170BACKGROUND
Biospecimen
whole blood serum blood culture bottles
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johan van Griensven, PhD, MD
Institute of Tropical Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2020
First Posted
February 13, 2020
Study Start
June 1, 2019
Primary Completion
August 31, 2019
Study Completion
December 30, 2020
Last Updated
May 11, 2021
Record last verified: 2021-05